ESR1 and breast cancer: To assess the effectiveness of GPs in killing cancer cells, colorimetric MTT assays were conducted on A549 human lung cancer cells, MDA-MB-231 (estrogen-receptor-negative) human breast cancer cells, U937 human leukemic cells, LLC mouse Lewis lung carcinoma cells, and EL4 mouse lymphoma cells.